Business Context and Reporting Period
Company: BioHarvest Sciences Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2026 (Event date: September 3, 2026)
Headquarters: Vancouver, British Columbia, Canada
The filing discloses a corporate event rather than financial results. On September 3, 2026, the Company issued a press release announcing its registration for dual listing on the Tel Aviv Stock Exchange (TASE).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves solely to distribute a news release regarding the TASE listing and does not contain financial statements or performance data.
Material Changes
Corporate Action: The Company has registered for dual listing on the Tel Aviv Stock Exchange (TASE).
Comparison: No financial comparison to prior periods is available in this document.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release detailing the TASE listing initiative. No specific financial guidance, outlook, or risk factors are detailed within the text of this Form 6-K.
Unusual Items: None reported in this specific filing.
Investor Verification Checklist
- Verify the status and timeline of the dual listing on the Tel Aviv Stock Exchange (TASE).
- Review the attached Exhibit 99.1 (News Release dated September 3, 2026) for specific details on the listing process.
- Check subsequent filings for any financial impact or capital raising activities related to the TASE listing.
- Confirm the Company's continued compliance with Form 40-F reporting requirements.